Pfizer Receives AUA Health Science Award
29 Apr 2023
BALTIMORE, April 29, 2023 /PRNewswire/ -- The American Urological Association (AUA) today announced that Pfizer Oncology is the recipient of the 2023 Health Science Award for its outstanding support of the educational, scientific and research goals of the AUA and the Urology Care Foundation in urologic cancer.
"We are proud to recognize Pfizer Oncology as the recipient of the 2023 Health Science Award," said Edward M. Messing, MD, FACS, president of the AUA. "Pfizer Oncology has become an instrumental partner with the AUA to support urologists seeking healthcare information to inform patient care."
The Health Science Award is presented annually to a company for its outstanding help in promoting the educational, scientific and research goals of the AUA. The presentation of this honor was held in conjunction with the 2023 AUA Annual Meeting in Chicago, Ill., on Saturday, April 29, 2023.
About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has nearly 24,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.
View original content to download multimedia:
SOURCE American Urological Association
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.